TIME: DIY alternatives for when stores are out of coronavirus-fighting products
UC expert says whatever is used, proper hand washing techniques are key
TIME Magazine interviewed Dr. Carl Fichtenbaum of UC's Division of Infectious Diseases for a story on do-it-yourself sanitizer ingredients.
Dr. Carl Fichtenbaum in a lab in the Division of Infectious Diseases at the UC College of Medicine. Photo credit/Joe Fuqua II/UC Creative + Brand
Dr. Fichtenbaum says no matter what ingredients are used, the most important element is proper hand washing techniques.
“Most of the data that’s been generated looking at enveloped viruses [like SARS-CoV-2], involves observed hand-washing for 30 seconds,” says Dr. Fichtenbaum.
He also touched on the topic of homemade masks.
“If I have the virus and I wear a homemade mask, the benefit is that it will stop some of the [virus-containing] droplets from going further around the room,” says Fichtenbaum. “It is not at all clear that the aerosol generated by coughing or sneezing is going to be stopped, especially if the particles are less than five microns.”
Read the entire article here.
Featured photo at the top: Justin Sullivan/Getty Images
Find the latest details related to coronavirus disease 2019 (covid-19) on the Centers for Disease Control and Prevention (CDC) website, and follow UC's latest information with regard to the virus.
Related Stories
Selecting noninvasive tests for liver disease diagnosis, monitoring
September 3, 2026
Noninvasive tests have emerged as valuable alternatives for diagnosing, staging and monitoring MASLD and MASH, according to a recent MedCentral report.
Why can it get so hot at times?
September 3, 2026
Cincinnati is experiencing more days of extreme heat this summer than in previous decades, due in large part to warmer global temperatures. But explanations for these higher temperatures also relate to regional factors, including the city's location in a river valley and large proportion of built environment.
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.